- 1D
- 3D
- 1W
- 1M
- 6M
- 1Y
- 3Y
- 5Y
Announcements
- Annual Report & Financial Statements - 31 Dec 2023
- Response to Share Price Movement
- Positive Results: Midkine mRNA and STAT-6 siRNA
- Operations Update
- Change of Auditor
- Significant Mesodermal Killer Cell Milestone
- Interim Results to 30 June 2023
- Investor Presentation via Investor Meet Company
- Expansion of Patent Portfolio
- Development of New Novel siRNA Therapeutics
More ▼
Key statistics
On Wednesday, Roquefort Therapeutics PLC (ROQ:LSE) closed at 4.55, 18.18% above the 52 week low of 3.85 set on Apr 05, 2024.
52-week range
Open | 4.55 |
---|---|
High | 4.60 |
Low | 4.60 |
Bid | 4.00 |
Offer | 5.50 |
Previous close | 4.55 |
Average volume | 197.55k |
---|---|
Shares outstanding | 129.15m |
Free float | 37.48m |
P/E (TTM) | -- |
Market cap | 5.88m GBP |
EPS (TTM) | -- |
Data delayed at least 20 minutes, as of May 08 2024 16:25 BST.
More ▼